Reprints of Past Articles
Choose a Reprint Topic Area Physician Marketing, Sales, and Education
- Physician Education (CME)
- Physician Marketing & Promotion
- MSLs and KOL Management
- Sales Force Effectiveness
Consumer Marketing and Education
Marketing Techniques and Tools
- Market Research
- Customer Relationship Management (CRM)
- Brand Marketing
- Relationship Marketing
- eMarketing and ePromotion
Regulatory Compliance, Privacy and Strategy
Miscellaneous
- Product & Service Reviews — Where the rubber meets the road!
- Global Pharma Marketing Practices — Thinking outside the States!
Choose a Reprint by Date of Publication Choose year:
2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 |
2011
June 8, 2011 (Vol. 10, Issue #10)
Executive Summary of Complete Issue
- The Pharmaguy Social Media Timeline™
- Finding the Consumer Within the Patient
- New Facebook Policy “Kind of Hurts” Pharma Marketers
- FDA, DOJ, & Google: Conspiracy Theory, Part 2
- FDA Drops “Social Media” from Its 2011 Guidance Agenda
- First FDA Social Media Guidance to Address Responding to “Unsolicited Requests” for Off-label Information
May 18, 2011 (Vol. 10, Issue #9)
Executive Summary of Complete Issue
- Pharma SmartPhone/Tablet Apps: Is There a Regulation for That?
- Challenges of Regulating Mobile Medical Apps
- FDA’s BadAd Program Lacks Credible Evidence
- eDetailing Technology & Birth of “Sales Cyborg”
- Physicians Are Concerned That Pharma Supported CME is Biased, But …
- FDA v. Google & Those 14 Infamous Warning Letters
April 28, 2011 (Vol. 10, Issue #8)
Executive Summary of Complete Issue
- Physicians Favor Brands With a Compelling Adherence Program
- Implications of Facebook’s Page Commenting Changes
- A New Estimate of Drug Development Cost
- FDA Plans to Test New Standard for Easy to Understand Rx Labels
- FDA’s Bad Ad Program is “Phoniest Thing Ever!”
- Pharma Even More Digitally Feeble When it Comes to Healthcare Providers
April 15, 2011 (Vol. 10, Issue #7)
Executive Summary of Complete Issue
- The Changing Role of Pharma Sales Reps
- Mining Mobile Health App User Data
- (Little) Used Drug for Sale. GSK Says, Bye Bye Alli!
- Ad Dollars Follow Eyeballs to Web
- Phil Mickelson is Now Regulated by FDA
- Brits Beat FDA & PhRMA: Issue Social Media Guidance for Pharma
March 30, 2011 (Vol. 10, Issue #6)
Executive Summary of Complete Issue
- Adverse Event Reporting: A Missed Opportunity
- Pharma TeleWeb e-Detailing
- Physicians Favor Brands with Compelling Adherence Platform
- Are Sales Reps as “Useful” as PhRMA Wants Us to Believe?
- Astellas Scientist Shows How to Light Ice on Fire!
- FDA Promises Still More Guidance! This Time It’s Mobile.
March 10, 2011 (Vol. 10, Issue #5)
Executive Summary of Complete Issue
- Pharma Twitter Pioneers Recognized
- Evidence-Based Pharma Marketing
- Astrazeneca’s Twitter Survey: Will They Share Some Results?
- Method Acting for Real Patients Who Play Themselves on Pharma YouTube Channels
February 23, 2011 (Vol. 10, Issue #4)
Executive Summary of Complete Issue
- Will Critics Kill Pharma’s Social Media Golden Egg Laying Goose? (pdf)
- HCP Marketing Beyond the Physician: Plugging Into NPs and PAs
- Google’s New OneBox Rx “Ads” Steal Clicks from Organic Branded Rx Search Results
- OMG! AstraZeneca Hosts Twitter Chat & World Does NOT End!
- AstraZeneca Hosts “Take on Depression” Facebook Discussion – Seroquel Lurks Behind the Scenes
- Phil Mickelson “Opens Up” to Arthritis Today Magazine
February 17, 2011 (Vol. 10, Issue #3)
Executive Summary of Complete Issue
- Good Promotion Practices Alliance
- Breaking the 140-character Limit of Twitter Opens the Door to FDA-Compliant Branded Tweets
- FDA’s Abrams Spends 4 Minutes Discussing Social Media Guidance at ePharma Summit!
- The Socialisation of the Internet is Bogus
- GSK’s U.S. Sales Reps “Europeanized”: No Longer Rewarded for Ability to Push Prescriptions
January 19, 2011 (Vol. 10, Issue #2)
Executive Summary of Complete Issue
- Deal with Lack of Regulations by Developing Best Practices (pdf)
- Strategies for Marketing Compliance
- Getting Market Research Right in India & China
January 12, 2011 (Vol. 10, Issue #1)
Executive Summary of Complete Issue
- Welcome to the 2010 Pharma Marketing YearBook™
- Events I Witnessed, News You Made, & People We Met
- Pharma Social Media Trials & Tribulations
- Pharma Spending on Internet, DTC, and Docs
- Pharma Companies Behaving Badly
2010
December 2010 (Vol. 9, Issue #10)
Executive Summary of Complete Issue
- Up Front: Pharma’s 2010 Christmas Wish List for Santa
- New Media Privacy Issues & Online Health Marketing
- Pfizer’s Latest Lyrica DTC Ad Should Be Cited By FDA as Misleading
- Ad Execs Not Viewed as Innovative By Americans Says AstraZeneca Survey
- Pfizer’s Sales Reps Have 48 Hours to Out Deliver eSampling Program
November 2010 (Vol. 9, Issue #9)
Executive Summary of Complete Issue
- Up Front: Pharma Collaboration with Online Patient Opinion Leaders
- Physician-Generated Content on Social Media Sites
- Getting Market Research Right in the Middle East
- Capturing & Reporting HCP-Related Meeting Spending
October 2010 (Vol. 9, Issue #8)
Executive Summary of Complete Issue
- Up Front: Social Media and the Limitations of Disease Awareness Campaigns
- Integration of Custom Media into the Marketing Mix
- Digital Pharma Is Alive and Well in Europe!
- Getting Market Research Right in Emerging Markets
September 2010 (Vol. 9, Issue #7)
Executive Summary of Complete Issue
- Up Front: Solving the Adherence Problem in Economic Hard Times
- Pharma, Physicians, and Sermo
- Eyes on the Adherence Prize
- Closed-Loop Patient Education
Summer 2010 (Vol. 9, Issue #6)
Executive Summary of Complete Issue
- Up Front: Just-in-Time Publishing
- The iPad as a Pharma Marketing Platform
- Social Media Leaders Wanted
- The Pharmaguy Next Door
May 2010 (Vol. 9, Issue #5)
Executive Summary of Complete Issue
- Up Front: Pharma Crisis Communications in the Fast-paced World of Twitter et al
- The Changing Pharma Commercial Model in 2010 and Beyond
- ePrints NRx for Physician Detailing
- Data Mining in the Deep, Dark Social Networks of Patients
April 2010 (Vol. 9, Issue #4)
Executive Summary of Complete Issue
- Up Front: What’s Your Social Media Implementation Plan?
- Real Patient Testimonials
- How to Manage the Online Conversation
- Moderation Best Practices for Pharma Social Networks
- Use of Social Media for Health Purposes in the EU
March 2010 (Vol. 9, Issue #3)
Executive Summary of Complete Issue
- Up Front: FDA Can Relax. I Did All the Work for Them!
- Industry and Consumer Advocates Square Off Regarding Social Media
- Overcoming Space Limitations in Social Media
- Accountability for Pharma Content on Social Media Sites
- Solving the Social Media Adverse Event Reporting Problem
February 2010 (Vol. 9, Issue #2)
Executive Summary of Complete Issue
- Up Front: Waiting for Goduidance
- Use of Twitter for Patient Support
- Building the “New” Pharma Physician Marketing Model
- Pharma’s Social Media Working Group
- Use of Behavioral Targeting by Pharma Marketers
January 2010 (Vol. 9, Issue #1)
Executive Summary of Complete Issue
- Up Front: Healthcare Communications vs. Pharma Marketing
- Predicting the Future of the Drug Industry
- Corporate Reputation in the New Media World
- Pharma Begins to Reveal Payments to Physicians
2009
November/December 2009 (Vol. 8, Issue #10)
Executive Summary of Complete Issue
- Up Front: What’s Next from the FDA?
- Consequences of Direct-to-Consumer Advertising
- Search Advertising Options for Pharma
- A Few Things I Learned at FDA’s Social Media Hearing
- Pharma’s Image Conundrum: Building Brand Loyalty and Consumer Confidence
October 2009 (Vol. 8, Issue #9)
Executive Summary of Complete Issue
- Up Front: Fear and Loathing in Washington, DC
- Social Media Adverse Event Reporting Safe Harbors: It’s Time for FDA to Open Up the Internet to Rx Advertising Like It Did with TV!
- Pharmaceutical Market Access 2010: Strategic Developments Impacting the US, EU, and Emerging Markets
- Risk Mitigation and Its Impact on Pharma Marketing: Appropriate Use Benefits After Launch
September 2009 (Vol. 8, Issue #8)
Executive Summary of Complete Issue
- Up Front: Let’s Respond to FDA’s Questions Regarding Its Regulation of Social Media
- What If There Were No Rules in Pharma Marketing?: Be Sure Not to Cut Off the Ends of Your Ham
- Pharma-Sponsored Medical Ghostwriting: What the Ghosts Have to Say About It
- Pharmaguy’s Twitter Followers: What Do They Want and How Is It Relevant to You?
August 2009 (Vol. 8, Issue #7)
Executive Summary of Complete Issue
- Up Front: Social Media & the Truncated News Pyramid
- Owning the Prescription Pad: Driving Brand Decisions in a Multi-Influence World
- Social Communications in Healthcare: Summary of Roundtable Discussions
- Waning Pharma Support of CME: The Plight of For-Profit MECCs
June/July 2009 (Vol. 8, Issue #6)
Executive Summary of Complete Issue
- Up Front: Whither Twitter for Pharma?
- Pharma Marketers Dive Deeper Into Social Media: The Good, the Bad, & the Ugly Case Studies
- How Should Pharma Engage in Social Networks?: Thoughts on Best Practices
- FDA Draft Guidance on Risk: Reading the Tea Leaves
May 2009 (Vol. 8, Issue #5)
Executive Summary of Complete Issue
- Up Front: Will the Drug Industry be the Next Auto Industry?
- Protection from Brand Infection: Marketers Must Take Control of Their Brands, Especially Online
- Ramifications of FDA Regulatory Actions: Helping FDA Find a New Media Regulatory Pathway
- The New PhRMA Code and Beyond: Federal & State Laws are Eclipsing Self-Regulation
- From Nalty to “Nalts”: The Transformation of a Pharma Marketing Director into a “Viral Video Genius”
April 2009 (Vol. 8, Issue #4)
Executive Summary of Complete Issue
- Up Front: Social Media–Opportunity or Nightmare?
- Developing Guidelines for Pharma’s Use of the Internet & Social Media: A Call for a Public Hearing at FDA
- The Empowered Patient: What It Means for Pharma Marketers
- Socially Challenged Pharma: How Ready is Pharma to Engage In Social Media?
- Report from the Social Pharmer “Unconference”: Sowing Seeds of Social Media Change?
March 2009 (Vol. 8, Issue #3)
Executive Summary of Complete Issue
- Up Front: Syndication is da Bomb!
- Pharma’s Bad Rep or Bad Rap: Whatever! The Drug Industry Must Earn Back the Public’s Trust
- Will Healthcare be Rationed or Rational?: A Case for Supporting Comparative Effectiveness Research
- FDA’s Use of Social Media: Peanuts Today, Drugs Tomorrow!
- New Privacy Rules in Economic Stimulus Law: Will They Restrict Certain Pharmaceutical Marketing Practices?
February 2009 (Vol. 8, Issue #2)
Executive Summary of Complete Issue
- Up Front: My Pledge to Subscribers & Advertisers
- The View From ePharma Summit: Practicing What Was Being Preached!
- Building the Optimal Service Model: Creating the Right Physician Experiences to Drive Business
- The New Rules of Marketing & PR: Book Review and Insights for Pharma
- Sales Force Effectiveness Metrics: More Important Than Ever in a Tough Market
January 2009 (Vol. 8, Issue #1)
Executive Summary of Complete Issue
- Up Front: Is There Life After Pharma?
- The Future of DTC Advertising: Is a Perfect Storm Brewing?
- The ePharma Pioneer Club™: Convincing Pharma Marketers to Engage in “e”
- FDA Finalizes Guidance on Distribution of Reprints
- The Hypocrisy of Healthcare Marketing Restrictions: Stand Up for Healthcare Marketing Free Speech
2008
December 2008 (Vol. 7, Issue #10)
Executive Summary of Complete Issue
- Up Front: Prepare or Die!
- The Changing Policy Landscape: Prepare Now for the Coming FDA and Pharmaceutical Marketing Reforms
- Patient Assistance Program Rankings: Going Beyond Sales Force Effectiveness to Customer Experience Satisfaction
- Critical: What Daschle Plans to Do About the Healthcare Crisis
- Reforming the FDA: It All Starts with a New Commissioner!
November 2008 (Vol. 7, Issue #9)
Executive Summary of Complete Issue
- Up Front: Time for a New & Improved FDA Commissioner
- Free Drug Samples: The Sales Rep’s Last Great Hope?
- Optimizing Market Access: A Guide to Effective Pricing, Reimbursement and Messaging Strategies
- Measuring & Communicating eSuccess: Strategy First, YouTube Later… Maybe
October 2008 (Vol. 7, Issue #8)
Executive Summary of Complete Issue
- Up Front: Good Luck to Us All!
- Obama v. McCain Survey Results
- Medical Device Marketing
- Global Pharma Competitive Intelligence
- The State of CME in Europe
- Turning Science into Sales
September 2008 (Vol. 7, Issue #7)
Executive Summary of Complete Issue
- Up Front: Who’s Better for Pharma: Obama or McCain?
- PhRMA’s New Code on Interactions with Healthcare Professionals
- Building Power Sales Messages
- Current Issues and Future Prospects for Sales Force Effectiveness
- India’s Booming Pharmaceutical Market
June/July 2008 (Vol. 7, Issue #6)
Executive Summary of Complete Issue
- Up Front: Going Global, Networking Reception Highlights, Vendor Video Showcase
- Why Pharmaceutical Marketers Ignore ROI
- Creating the Most Effective Sales Calls
- Diversity in the Life Sciences
- Value-based Pricing
May 2008 (Vol. 7, Issue #5)
Executive Summary of Complete Issue
- Moving the Needle on Adherence
- High Impact Content in Support of Rx Brands
- How to Get Your Message In Front of Pharma Brand Managers
April 2008 (Vol. 7, Issue #4)
Executive Summary of Complete Issue
- DTC Risk Communication
- Building a Blockbuster
- Guerilla Pharma Marketing
- Reporting Gifts to Physicians
March 2008 (Vol. 7, Issue #3)
Executive Summary of Complete Issue
- I’m All a Twitter Over Twitter
- The Coming Pharma Marketing Recession
- Tips for Improving Pharma Sales
- What Americans Think About Drug Advertising
- Closed Loop Marketing
- Pharma’s Social Media Marketing Readiness Score
February 2008 (Vol. 7, Issue #2)
Executive Summary of Complete Issue
- Jarvik: A Modern DTC Tragedy
- FDA’s Good Reprint Practices Guidance
- Helping Pharma eMarketing “Grow up”
- Understanding the Strategic Value of MSLs
- Prescription Drugs and the Health 2.0 Opportunity
January 2008 (Vol. 7, Issue #1)
Executive Summary of Complete Issue
- DTC User Fees Go PDUffft!
- Use of Celebrities for PR and DTC Advertising
- Pharma Marketing Network 2007 Report
- Wither CME?
- Is It Time to End Industry Sponsored CME?
- Cholesterol Drug Users Discuss Their Medication
2007
November/December 2007 (Vol. 6, Issue #10)
- Diversity in Pharma
- Mapping New Paths through the DTC Marketing Mix Maze
- Accomplishing Adherence
- Medical Transcript Advertising
- Pharma Marketing Roundtable – Members Only!
- New Social Media Regulatory Framework
October 2007 (Vol. 6, Issue #9)
- Awards. What Are They Good For?
- Collaborating with Online Physician Communities
- Rep Access Programs
- Re-Designing the Pharma Sales Force
- Pharmaceutical Competitive Intelligence
September 2007 (Vol. 6, Issue #8)
- DTC, for Better or Worse, is Here to Stay
- Surviving the Election Wars
- Web 2.0 Pharma Marketing Tricks for Dummies
- Measuring Consumer Sentiment About Prescription Drugs
- Pharma Marketing Stuck in Web 1.5
July/August 2007 (Vol. 6, Issue #7)
- J&J’s PR Hindenburg Disaster!
- Merck Rejiggers Its Marketing Mix
- Stop Wasting $Millions on Ineffective DTC Ads!
- The Changing Landscape of Physician Interactions
- A Tale of Two Pharma Whistleblower Novels
June 2007 (Vol. 6, Issue #6)
- One…uh, Two Small Steps for Pharmaco Blogging!
- SiCKO is Boffo but Not Anti-Pharmaco Per Se
- Big Pharma Sales Analytics for the Rest of Us
- Got Game? Online Pharma Advergaming
- From Science to CEO: The Scientific Path to Corporate Leadership
May 2007 (Vol. 6, Issue #5)
- Moore: Please Don’t Ignore Us Pharma Bloggers
- Measuring an Intangible: Medical Science Liaison Metrics Consensus
- Optimizing Brand Equity: Pre-Launch through Patent Expiry and Beyond!
- Mobile Pharma Marketing: What’s the 411?
- Murky Physician Marketing and Education Practices
April 2007 (Vol. 6, Issue #4)
- Full Disclosure
- How Readable, Credible & Useful are Pharma Blogs?
- Targeted Faith-based Disease Awareness Marketing
- Americans Skeptical of Pharma Cause Marketing
- YouPharma: New Rules for Pharma Marketing and Social Media
- A Primer on Pharma Employee Blogging
March 2007 (Vol. 6, Issue #3)
- Should Bloggers Dine at Pharma’s Table?
- Disease Mongering: When Is the Line Crossed?
- Innerstate: The First Disease Awareness Documentary Film
- Are Pharma Bloggers Biased Against the Industry?
February 2007 (Vol. 6, Issue #2)
- God Bless R&D, but Marketers May Go to Hell!
- The Expanding Pharma Blogosphere
- Surfing the eMarketing Big One!
- Social Network Marketing: The Wisdom of the Crowd
- What’s Next vs. What’s Best
January 2007 (Vol. 6, Issue #1)
- Word-of-Net
- Are Sales Reps Necessary?
- Reinventing the Sales Model
- Sales Reps Debate Their Value
- An Online Community to Call Our Own
2006
November/December 2006 (Vol. 5, Issue #10)
- Betting the Pharm
- Congress vs. Pharma: Trouble Ahead?
- Pharma’s Plodding Approach to eMarketing
- Sales Effectiveness Meets eMarketing
- Teaching New Dogs Old Tricks
October 2006 (Vol. 5, Issue #9)
- Interpretation of Ads
- e-Inertia Plagues the Pharma Industry
- Optimizing DTC Performance
- The Brand Marketing Mix
- Pharma Online Spending
September 2006 (Vol. 5, Issue #8)
- Numbers
- Print DTC: How Does It Measure Up?
- Fast Start to Customized ePromotion and eLearning Physician Programs
- Pharma’s Black Knight Confesses All!
- Pharmacy TeleStocking
July/August 2006 (Vol. 5, Issue #7)
- Engagement
- PR: Advertising by Other Means
- Relationship Marketing via eNutrition
- Physician Meetings: Education Works Both Ways
- MSL Roles & Goals
June 2006 (Vol. 5, Issue #6)
- Could Chill Kill CME?
- Trends in Commercial Support of CME
- Slides: The Currency of Communication
- Free Prescription Drug Cards
- Whose Data Is It Anyway?
May 2006 (Vol. 5, Issue #5)
- Doing a Good Job but Still Not Trusted!
- The Changing World of MSLs: Determining Value
- Biotech DTC: Business Not As Usual
- Peter Rost: Whistle Blower, Pharma Blogger, ???
April 2006 (Vol. 5, Issue #4)
- Disease Mongering
- Communicating Risk: Let the Dialog Begin
- Merit of CHC Petition to FDA
- Managing Reprints for Better Clinical Support of Marketing
- The Electronic Formulary Will Change the Equation
March 2006 (Vol. 5, Issue #3)
- Buzz ‘n Blog Marketing
- The European eMarketing Scene: Desperately Seeking Strategy
- European Online Marketing Survey Results
- Effective Physician Marketing at Medical Meeting Exhibits
- Paid Inclusion: Too Hot for Pharma Marketing?
February 2006 (Vol. 5, Issue #2)
- Pharma McCarthyism
- Free Gifts to Physicians: What’s the Big Deal?
- What Pharma Companies Spend on Gifts to Docs
- Branded Physician Education: How to Integrate Promotion and Education
- Hard Sell: The Evolution of a Generation X Salesman
January 2006 (Vol. 5, Issue #1)
- The End of DTC as We Have Known It
- Pharma Trends to Watch in 2006
- Direct to Physician Telemarketing and Sales
- Pfizer France: Viva la SFE Difference!
- Women in Pharma
2005
December 2005 (Vol. 4, Issue #11)
- “Tribal Marketing”
- Blogs and the Pharmaceutical Industry
- DocCheck: Das Portal
- Generation Rx: A History and Critique of Pharma “Tribal Marketing”
November 2005 (Vol. 4, Issue #10)
- Pharma Marketing Blog a “Must Read”
- DTC Pros and Cons Presented at FDA Hearing
- Predictive Physician Marketing
- GSK Strikes Back with a Grassroots Campaign
- Global Digital Asset Brand Management
- Sales Rep Assessment: Shoot the Messenger, the Message, or Both?
October 2005 (Vol. 4, Issue #9)
- Surveys Say…
- eDetailing: Yesterday, Today and Tomorrow
- Managing Cross Boundary Issues
- Society of Industry Leaders: Help for Investors
- Mobile Medical Reference: An Effective Door Opener for Sales Reps
September 2005 (Vol. 4, Issue #8)
- It’s the Science, Stupid!
- cDetailing: Addressing the Consumer Education Gap
- The Evolving Impact of Anti-Spam Legislation on Online Marketers
- Patient Detailing at the Point of Care
- Midwestern eMarketing Values
July/August 2005 (Vol. 4, Issue #7)
- Restrict DTC, but Extend the Patent for New Drugs
- To Ban or Not to Ban DTC, That is the Question
- Marketing the Pharma Industry: The Empire Strikes Back
- Translate Industry Trends into the Optimal Promotional Strategy
- A Call to Action: A Mea Non Culpa by Big Pharma
June 2005 (Vol. 4, Issue #6)
- Transparency is the Word These Days
- Compliance with (Some) New ACCME Rules Not So Easy
- Protecting Your Brand with Anti-Counterfeiting Solutions
- Limbic Market Research: Plumbing the Subconscious Motivators of Physicians
- Drug Risk Survey Results
- A Strategic Approach to CME Offers High Return on Education Investment
- Pharma BloggoSphere Update
May 2005 (Vol. 4, Issue #5)
- A Good Time Was Had by All
- A Proposal for a Drug Risk Advisory System
- Thought-Leader Management: A Challenge Met
- Marketing in the Post-Vioxx Era
- Return on CME: Are Pharma Companies Getting Desired Outcomes?
- Is Pharma Marketing a Lot of BS?
April 2005 (Vol. 4, Issue #4)
- Separation of Church and State
- E-mail Marketing Best Practices for Pharma
- Measuring Marketing Strategy
- Beyond the eDetail: Evolving to Educate
- Growing Pharmaceutical Sales Utilizing Six Sigma and Lean
- Survey Results: Straight-Talking DTC
March 2005 (Vol. 4, Issue #3)
- Give Docs What They Want
- Marketing’s Role in Limiting Physician Access and What to Do About It
- Increase Prescription Sales with Smart Tools
- How to Sell a Drug Before it is Approved
- Leverage Health Beliefs to Develop Effective Online Compliance Programs
- Applying FDA Marketing Regulations to Internet Promotions
- Cost-Cutting Strategies for the Pharma Industry
February 2005 (Vol. 4, Issue #2)
- Times They Are A-Changing?
- You May Walk Like a Duck and Quack Like a Duck, But You’re No Duck!
- Relationship Marketing Program Management for Pharmaceutical Marketers
- DTC in 2005: Can You Teach Old Dogs New Tricks?
- Numbers, Math and Communicating Risk
- Does the FDA Need to be Overhauled?
January 2005 (Vol. 4, Issue #1)
- Blogging My Way Into 2005!
- Can Health Web Sites Improve Compliance?
- Facilitating Physician Access and Education Through Online Conferencing
- MSL Role in Educational Development
- Motivating & Retaining The MSL: What Makes MSLs Tick
- Managing Medical Science Liaisons From Afar
- A Web-based Therapy Management Program
- Drug Prices, Declining Profits Top Issues for 2005
2004
November/December 2004 (Vol. 3, Issue #10)
- Corporate “Moral Values” Anyone?
- The Truth About the Drug Companies: What To Do About It
- Creating a Successful DTC Campaign on the Inside
- A Novel Approach to Communicating with Physicians
- Is Your Product Ready for Consumers?
- Will COX-2 Inhibitors Crash and Burn?
October 2004 (Vol. 3, Issue #9)
- Vioxx Withdrawal and the “Me-Too Drug Domino Effect”
- Physician Adoption and Use of Technology at the Point of Care
- The Role of Tablet PCs in Pharma Sales and Marketing
- Strategies for Enhanced Physician Targeting and Segmentation
- No More Free Lunch in California?
- Drug Reimportation Survey Results
September 2004 (Vol. 3, Issue #8)
- Drug Importation Crisis: Terror Politics to the Rescue!
- The Indian Pharmaceutical Market
- Congress Fiddles While Reimportation Issue Burns
- Becoming Woman Wise: Marketing Healthcare to Women
- Accelerating Your Multicultural Communications
- How Cheap are Canada’s Drugs Really?
July/August 2004 (Vol. 3, Issue #7)
- The Price of Drugs
- California’s Physician Prescribing Act: A History of Twists and Turns
- A Crisis in Professional Detailing
- The Targeted Model: The Future of Pharmaceutical Marketing?
June 2004 (Vol. 3, Issue #6)
May 2004 (Vol. 3, Issue #5)
- Pushing the Envelope is Bad for DTC
- Searching for Answers on Search Engine Marketing?
- European Compliance Not Only Possible, But Leading Edge
- The Revitalized Brand: Creating a New Brand Image from an Old Product
- Branding as a Management Tool in Pharma
- Direct-To-Consumer Advertising: Developing Evidence-Based Policy To Improve Retention And Comprehension
April 2004 (Vol. 3, Issue #4)
- The Future of Big Pharma
- Intelligent Online Sampling Strategies
- The Internet and CME
- When Is Commercial Support Appropriate for CME Activities?
- Emotions, Focus and Storytelling: How Cialis is Challenging Viagra
- Maximizing the DTC Message: Healthcare Businesswomen’s Association Members Evaluate DTC Marketing
March 2004 (Vol. 3, Issue #3)
- Want to Know What Really Sucks?
- Scenarios on the Future of Pharma Marketing: No Time Like the Present to Think the Unthinkable
- Medical Science Liaisons: Working between Two Worlds
- Effective Pharma Adherence Programs Start With The Patient
- To Build Patient Adherence, Pfizer Puts Technology Behind The Curtain
- Your Pharma Marketing Sucks
- The New Written Prescription: Leveraging Technology to Measure Change in Physician Behavior as it Occurs
February 2004 (Vol. 3, Issue #2)
- Is DTC Educational or Motivational?
- Key Issues Facing DTC Marketers in 2004
- Beyond Patient Education: Influencing Behavior Change
- FDA Draft Guidance for Print DTCA: Less than Feared
- Super Bowl DTC Debut: Was It Good for You?
- Beyond DTC: Consumer Relationship Satisfaction
January 2004 (Vol. 3, Issue #1)
- Controlling Your Brand’s Switch Destiny
- Finding the “Right Stuff” to Revitalize Sales Productivity
- Spam spam spam spam. Lovely spam! Wonderful spam!
- Strategies for Overcoming the Internal Challenges between Rx and OTC
- What You Need to Know About the New “CAN-SPAM” Law
2003
December 2003 (Vol. 2, Issue #11)
- The FTC-Lilly Consent Decree: What it Means for PHARMA Vendors and Partners
- Guidelines for Off-label Communications
- Integrating Compliance into Commercial Practices
- Managing Privacy Risks in Your Commercial Practices
- PhRMA Code Succeeding…So Far
- Pharma’s Confidence Crisis: A Call for a New Marketing Paradigm?
November 2003 (Vol. 2, Issue #10)
- Balancing Idealistic vs. Realistic CRM Processes
- Developing Win-Win Key Opinion Leader Relationships
- Putting the Customer Back in Customer Relationship Management
- Relationships
- Tailoring CRM Solutions to Your Business Strategy
October 2003 (Vol. 2, Issue #9)
- The Future of eDetailing
- The Impact of eDetailing: Will it Complement, Replace, or Become Integrated with the Sales Force?
- Optimizing eDetailing ROI
- Why Pharma Can’t Ignore eDetailers
September 2003 (Vol. 2, Issue #8)
- Branding Internally: Think Brand, Not Product
- Evolve Your Brand into a Relationship with Consumers and Physicians
- What the Next Generation Physician Wants from Pharma
July 2003 (Vol. 2, Issue #7)
- Out-of-the-Box Marketing: Will It Work for Pharma?
- Patient-Level Data: A New Level of Analysis
- Understanding Drivers of Patient Behavior to Maximize DTC Effectiveness
June 2003 (Vol. 2, Issue #6)
- It’s All About Education
- Online CME – A Glass Half-Full or Half-Empty?
- Provider/Pharmaceutical Partnerships – Are They Possible Without Conflict of Interest?
- Responding to the Challenges of Evolving Regulation
- Understanding the Proposed ACCME Standards for Commercial Support
May 2003 (Vol. 2, Issue #5)
- Drug Marketers Need More Than Demographic Data To Effectively Market To Consumers
- Ethical Online Practices Build Consumer Trust
- Pharmaceutical Marketing in Texas: look out for state privacy laws!
- Proactive e-Marketing Plan
- Product Branding, e-Marketing May Be Underutilized
April 2003 (Vol. 2, Issue #4)
- e-Marketing at the Point of Care
- Pharma Marketing Network Survey Results
- PhRMA Code Helps Re-define Roles of Medical Affairs and Marketing
March 2003 (Vol. 2, Issue #3)
- Consumer Use of the Internet for Health: Whose Numbers Do You Believe?
- Integrating Online & Offline Marketing: Challenges for Pharma
February 2003 (Vol. 2, Issue #2)
January 2003 (Vol. 2, Issue #1)
- Has DTC Spending Peaked?
- Online and Offline Professional and Consumer Marketing
- Results from FDA Physician Survey on DTC Advertising
- Top Companies, Classes, and Products in the DTC Space
2002
November 2002 (Vol. 1, Issue #9)
October 2002 (Vol. 1, Issue #8)
- Personalized e-Marketing – How can you create and profit from a customer’s lifetime experience?
- What Stands in the Way of the Mainstream Use of the Internet by Pharmaceutical Companies?
September 2002 (Vol. 1, Issue #7)
- The Absolute, Relative, and Incremental ROI of DTC e-Marketing
- Product Web Sites: Are They Worth It?
February 2002 (Vol. 1, Issue #2)
Choose a Reprint by Title Choose letter:
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | Y |
A…
- The Absolute, Relative, and Incremental ROI of DTC e-Marketing
- Accomplishing Adherence
- Accountability for Pharma Content on Social Media Sites
- A Call to Action: A Mea Non Culpa by Big Pharma
- A Few Things I Learned at FDA’s Social Media Hearing
- A Good Time Was Had by All
- Ad Dollars Follow Eyeballs to Web
- Americans Skeptical of Pharma Cause Marketing
- An Online Community to Call Our Own
- Applying FDA Marketing Regulations to Internet Promotions
- Are Pharma Bloggers Biased Against the Industry?
- Are Sales Reps Necessary?
- Awards. What Are They Good For?
B…
- Balancing Idealistic vs. Realistic CRM Processes
- Betting the Pharm
- Beyond DTC: Consumer Relationship Satisfaction
- Beyond Patient Education: Influencing Behavior Change
- Beyond the eDetail: Evolving to Educate
- Big Pharma Sales Analytics for the Rest of Us
- Biotech DTC: Business Not As Usual
- Blogging My Way Into 2005!
- Blogs and the Pharmaceutical Industry
- Branded Physician Education: How to Integrate Promotion and Education
- Branding Internally: Think Brand, Not Product
- The Brand Marketing Mix
- Brits Beat FDA & PhRMA: Issue Social Media Guidance for Pharma
- Building a Blockbuster
- Building the “New” Pharma Physician Marketing Model
- Building the Optimal Service Model: Creating the Right Physician Experiences to Drive Business
- Building Power Sales Messages
- Buzz ‘n Blog Marketing
C…
- California’s Physician Prescribing Act: A History of Twists and Turns
- Can Health Web Sites Improve Compliance?
- Capturing & Reporting HCP-Related Meeting Spending
- cDetailing: Addressing the Consumer Education Gap
- Challenges of Regulating Mobile Medical Apps
- The Changing Pharma Commercial Model in 2010 and Beyond
- The Changing Landscape of Physician Interactions
- The Changing Policy Landscape: Prepare Now for the Coming FDA and Pharmaceutical Marketing Reforms
- The Changing Role of Pharma Sales Reps
- The Changing World of MSLs: Determining Value
- Cholesterol Drug Users Discuss Their Medication
- Closed Loop Marketing
- Closed-Loop Patient Education
- Collaborating with Online Physician Communities
- The Coming Pharma Marketing Recession
- Communicating Risk: Let the Dialog Begin
- Compliance with (Some) New ACCME Rules Not So Easy
- Congress vs. Pharma: Trouble Ahead?
- Consequences of Direct-to-Consumer Advertising
- Consumer Use of the Internet for Health: Whose Numbers Do You Believe?
- Controlling Your Brand’s Switch Destiny
- Corporate Reputation in the New Media World
- Corporate “Moral Values” Anyone?
- Cost-Cutting Strategies for the Pharma Industry
- Could Chill Kill CME?
- Creating a Successful DTC Campaign on the Inside
- Creating the Most Effective Sales Calls
- A Crisis in Professional Detailing
- Critical: What Daschle Plans to Do About the Healthcare Crisis
- Current Issues and Future Prospects for Sales Force Effectiveness
D…
- Data Mining in the Deep, Dark Social Networks of Patients
- Developing Guidelines for Pharma’s Use of the Internet & Social Media: A Call for a Public Hearing at FDA
- Developing Win-Win Key Opinion Leader Relationships
- Digital Pharma Is Alive and Well in Europe!/A>
- Direct to Physician Telemarketing and Sales
- Disease Mongering
- Disease Mongering: When Is the Line Crossed?
- Diversity in the Life Sciences
- Diversity in Pharma
- DocCheck: Das Portal
- Does the FDA Need to be Overhauled?
- Doing a Good Job but Still Not Trusted!
- Drug Reimportation Survey Results
- Drug Marketers Need More Than Demographic Data To Effectively Market To Consumers
- Drug Prices, Declining Profits Top Issues for 2005
- Drug Risk Survey Results
- DTC, for Better or Worse, is Here to Stay
- DTC in 2005: Can You Teach Old Dogs New Tricks?
- DTC Pros and Cons Presented at FDA Hearing
- DTC Risk Communication
- DTC User Fees Go PDUffft!
E…
- eDetailing Technology & Birth of “Sales Cyborg”
- eDetailing: Yesterday, Today and Tomorrow
- The End of DTC as We Have Known It
- E-mail Marketing Best Practices for Pharma
- Emotions, Focus and Storytelling: How Cialis is Challenging Viagra
- e-Marketing at the Point of Care
- Effective Pharma Adherence Programs Start With The Patient
- Effective Physician Marketing at Medical Meeting Exhibits
- e-Inertia Plagues the Pharma Industry
- The Empowered Patient: What It Means for Pharma Marketers
- The ePharma Pioneer Club™: Convincing Pharma Marketers to Engage in “e”
- ePrints NRx for Physician Detailing
- The Electronic Formulary Will Change the Equation
- Engagement
- Ethical Online Practices Build Consumer Trust
- European Compliance Not Only Possible, But Leading Edge
- The European eMarketing Scene: Desperately Seeking Strategy
- European Online Marketing Survey Results
- Evolve Your Brand into a Relationship with Consumers and Physicians
- The Evolving Impact of Anti-Spam Legislation on Online Marketers
- Eyes on the Adherence Prize/A>
- The Expanding Pharma Blogosphere
F…
- Facilitating Physician Access and Education Through Online Conferencing
- Fast Start to Customized ePromotion and eLearning Physician Programs
- FDA Can Relax. I Did All the Work for Them!
- FDA, DOJ, & Google: Conspiracy Theory, Part 2
- FDA Drops “Social Media” from Its 2011 Guidance Agenda
- FDA Draft Guidance for Print DTCA: Less than Feared
- FDA Draft Guidance on Risk: Reading the Tea Leaves
- FDA Finalizes Guidance on Distribution of Reprints
- FDA’s Bad Ad Program is “Phoniest Thing Ever!”
- FDA’s BadAd Program Lacks Credible Evidence
- FDA’s Good Reprint Practices Guidance
- FDA’s Use of Social Media: Peanuts Today, Drugs Tomorrow!
- FDA Plans to Test New Standard for Easy to Understand Rx Labels
- FDA v. Google & Those 14 Infamous Warning Letters
- Fear and Loathing in Washington, DC
- Finding the Consumer Within the Patient
- Finding the “Right Stuff” to Revitalize Sales Productivity
- First FDA Social Media Guidance to Address Responding to “Unsolicited Requests” for Off-label Information
- Free Drug Samples: The Sales Rep’s Last Great Hope?
- Free Gifts to Physicians: What’s the Big Deal?
- Free Prescription Drug Cards
- From Nalty to “Nalts”: The Transformation of a Pharma Marketing Director into a “Viral Video Genius”
- From Science to CEO: The Scientific Path to Corporate Leadership
- The FTC-Lilly Consent Decree: What it Means for PHARMA Vendors and Partners
- The Future of Big Pharma
- The Future of DTC Advertising: Is a Perfect Storm Brewing?
- The Future of eDetailing
G…
- Generation Rx: A History and Critique of Pharma “Tribal Marketing”
- Getting Market Research Right in Emerging Markets
- Getting Market Research Right in the Middle East/A>
- Give Docs What They Want
- Global Digital Asset Brand Management
- Global Pharma Competitive Intelligence
- God Bless R&D, but Marketers May Go to Hell!
- Good Promotion Practices Alliance
- Got Game? Online Pharma Advergaming
- Growing Pharmaceutical Sales Utilizing Six Sigma and Lean
- GSK Strikes Back with a Grassroots Campaign
- Guerilla Pharma Marketing
- Guidelines for Off-label Communications
H…
- Hard Sell: The Evolution of a Generation X Salesman
- Has DTC Spending Peaked?
- Healthcare Communications vs. Pharma Marketing (pdf)
- Helping Pharma eMarketing “Grow up”
- High Impact Content in Support of Rx Brands
- How Readable, Credible & Useful are Pharma Blogs?
- How to Get Your Message In Front of Pharma Brand Managers
- How to Manage the Online Conversation
- How to Sell a Drug Before it is Approved
- How Should Pharma Engage in Social Networks?: Thoughts on Best Practices
- The Hypocrisy of Healthcare Marketing Restrictions: Stand Up for Healthcare Marketing Free Speech
I…
- I’m All a Twitter Over Twitter
- The Impact of eDetailing: Will it Complement, Replace, or Become Integrated with the Sales Force?
- Implications of Facebook’s Page Commenting Changes
- Increase Prescription Sales with Smart Tools
- India’s Booming Pharmaceutical Market
- Industry and Consumer Advocates Square Off Regarding Social Media
- Innerstate: The First Disease Awareness Documentary Film
- Integrating Compliance into Commercial Practices
- Integrating Online & Offline Marketing: Challenges for Pharma
- Integration of Custom Media into the Marketing Mix
- Intelligent Online Sampling Strategies
- The Internet and CME
- Interpretation of Ads
- The iPad as a Pharma Marketing Platform
- Is It Time to End Industry Sponsored CME?
- Is Pharma Ready for HIPAA?
- Is Pharma Marketing a Lot of BS?
- Is Your Product Ready for Consumers?
- It’s All About Education
- It’s the Science, Stupid!
J…
K…
L…
- Let’s Respond to FDA’s Questions Regarding Its Regulation of Social Media
- Leverage Health Beliefs to Develop Effective Online Compliance Programs
- Limbic Market Research: Plumbing the Subconscious Motivators of Physicians
- (Little) Used Drug for Sale. GSK Says, Bye Bye Alli!
M…
- Managing Cross Boundary Issues
- Managing Medical Science Liaisons From Afar
- Managing Privacy Risks in Your Commercial Practices
- Managing Reprints for Better Clinical Support of Marketing
- Mapping New Paths through the DTC Marketing Mix Maze
- Marketing in the Post-Vioxx Era
- Marketing the Pharma Industry: The Empire Strikes Back
- Marketing’s Role in Limiting Physician Access and What to Do About It
- Maximizing the DTC Message: Healthcare Businesswomen’s Association Members Evaluate DTC Marketing
- Measuring an Intangible: Medical Science Liaison Metrics Consensus
- Measuring & Communicating eSuccess: Strategy First, YouTube Later… Maybe
- Measuring Marketing Strategy
- Measuring Consumer Sentiment About Prescription Drugs
- Medical Device Marketing
- Medical Science Liaisons: Working between Two Worlds
- Medical Transcript Advertising
- Merit of CHC Petition to FDA
- Merck Rejiggers Its Marketing Mix
- Midwestern eMarketing Values
- Mining Mobile Health App User Data
- Mobile Medical Reference: An Effective Door Opener for Sales Reps
- Mobile Pharma Marketing: What’s the 411?
- Moderation Best Practices for Pharma Social Networks
- Moore: Please Don’t Ignore Us Pharma Bloggers
- Motivating & Retaining The MSL: What Makes MSLs Tick
- Moving the Needle on Adherence
- MSL Role in Educational Development
- MSL Roles & Goals
- Murky Physician Marketing and Education Practices
N…
- A New Estimate of Drug Development Cost
- New Facebook Policy “Kind of Hurts” Pharma Marketers
- New Media Privacy Issues & Online Health Marketing
- The New PhRMA Code and Beyond: Federal & State Laws are Eclipsing Self-Regulation
- New Privacy Rules in Economic Stimulus Law: Will They Restrict Certain Pharmaceutical Marketing Practices?
- The New Rules of Marketing & PR: Book Review and Insights for Pharma
- New Social Media Regulatory Framework
- The New Written Prescription: Leveraging Technology to Measure Change in Physician Behavior as it Occurs
- No More Free Lunch in California?
- A Novel Approach to Communicating with Physicians
- Numbers
- Numbers, Math and Communicating Risk
O…
- Obama v. McCain Survey Results
- One…uh, Two Small Steps for Pharmaco Blogging!
- Online and Offline Professional and Consumer Marketing
- Online CME – A Glass Half-Full or Half-Empty?
- Optimizing Brand Equity: Pre-Launch through Patent Expiry and Beyond!
- Optimizing Market Access: A Guide to Effective Pricing, Reimbursement and Messaging Strategies
- Optimizing DTC Performance
- Optimizing eDetailing ROI
- Out-of-the-Box Marketing: Will It Work for Pharma?
- Overcoming Space Limitations in Social Media
- Owning the Prescription Pad: Driving Brand Decisions in a Multi-Influence World
P…
- Paid Inclusion: Too Hot for Pharma Marketing?
- Patient Assistance Program Rankings: Going Beyond Sales Force Effectiveness to Customer Experience Satisfaction
- Patient-Level Data: A New Level of Analysis
- Patient Detailing at the Point of Care
- Personalized e-Marketing – How can you create and profit from a customer’s lifetime experience?
- Peter Rost: Whistle Blower, Pharma Blogger, ???
- Pfizer France: Viva la SFE Difference!
- Pharma Begins to Reveal Payments to Physicians
- Pharma BloggoSphere Update
- Pharma Collaboration with Online Patient Opinion Leaders
- Pharma eMarketing: A Level Playing Field or a Killing Field?
- Pharma Even More Digitally Feeble When it Comes to Healthcare Providers
- Pharma Marketing Blog a “Must Read”
- Pharma Marketing Network 2007 Report
- Pharma Marketing Network Survey Results
- Pharma Marketing Stuck in Web 1.5
- Pharma’s Confidence Crisis: A Call for a New Marketing Paradigm?
- Pharma’s Plodding Approach to eMarketing
- Pharma’s Black Knight Confesses All!
- Pharma Marketing Roundtable – Members Only!
- Pharma McCarthyism
- Pharma Online Spending
- Pharma, Physicians, and Sermo
- Pharma SmartPhone/Tablet Apps: Is There a Regulation for That?
- Pharma’s Social Media Working Group
- Pharma Trends to Watch in 2006
- Pharmaceutical Competitive Intelligence
- Pharmaceutical Compliance with Fair Information Practice Principles
- Pharmaceutical Market Access 2010: Strategic Developments Impacting the US, EU, and Emerging Markets
- Pharmaceutical Marketing in Texas: look out for state privacy laws!
- The Pharmaguy Next Door
- Pharmaguy’s Twitter Followers: What Do They Want and How Is It Relevant to You?
- Pharmacy TeleStocking
- Pharma Marketers Dive Deeper Into Social Media: The Good, the Bad, & the Ugly Case Studies
- Up Front: Pharma’s 2010 Christmas Wish List for Santa
- Pharma’s Bad Rep or Bad Rap: Whatever! The Drug Industry Must Earn Back the Public’s Trust
- Pharma’s Image Conundrum: Building Brand Loyalty and Consumer Confidence
- Pharma’s Social Media Marketing Readiness Score
- Pharma-Sponsored Medical Ghostwriting: What the Ghosts Have to Say About It
- Up Front: Pharma Crisis Communications in the Fast-paced World of Twitter et al
- Pharma TeleWeb e-Detailing
- Pharma Twitter Pioneers Recognized
- The Pharmaguy Social Media Timeline™
- Phil Mickelson is Now Regulated by FDA
- PhRMA Code Helps Re-define Roles of Medical Affairs and Marketing
- PhRMA Code Succeeding So Far
- PhRMA’s New Code on Interactions with Healthcare Professionals
- Physician Adoption and Use of Technology at the Point of Care
- Physicians Favor Brands With a Compelling Adherence Program
- Physician-Generated Content on Social Media Sites
- Physician Meetings: Education Works Both Ways
- Physicians Are Concerned That Pharma Supported CME is Biased, But …
- PR: Advertising by Other Means
- Predicting the Future of the Drug Industry
- Predictive Physician Marketing
- Up Front: Prepare or Die!
- Prescription Drugs and the Health 2.0 Opportunity
- The Price of Drugs
- A Primer on Pharma Employee Blogging
- Print DTC: How Does It Measure Up?
- Proactive e-Marketing Plan
- Product Branding, e-Marketing May Be Underutilized
- Product Web Sites: Are They Worth It?
- A Proposal for a Drug Risk Advisory System
- Protecting Your Brand with Anti-Counterfeiting Solutions
- Protection from Brand Infection: Marketers Must Take Control of Their Brands, Especially Online
- Provider/Pharmaceutical Partnerships – Are They Possible Without Conflict of Interest?
- Pushing the Envelope is Bad for DTC
- Putting the Customer Back in Customer Relationship Management
Q…
R…
- Ramifications of FDA Regulatory Actions: Helping FDA Find a New Media Regulatory Pathway
- Re-Designing the Pharma Sales Force
- Real Patient Testimonials
- Reforming the FDA: It All Starts with a New Commissioner!
- Reinventing the Sales Model
- Relationship Marketing via eNutrition
- Relationship Marketing Program Management for Pharmaceutical Marketers
- Relationships
- Rep Access Programs
- Report from the Social Pharmer “Unconference”: Sowing Seeds of Social Media Change?
- Reporting Gifts to Physicians
- Responding to the Challenges of Evolving Regulation
- Restrict DTC, but Extend the Patent for New Drugs
- Results from FDA Physician Survey on DTC Advertising
- Return on CME: Are Pharma Companies Getting Desired Outcomes?
- The Revitalized Brand: Creating a New Brand Image from an Old Product
- Risk Mitigation and Its Impact on Pharma Marketing: Appropriate Use Benefits After Launch
- The Role of Tablet PCs in Pharma Sales and Marketing
S…
- Sales Effectiveness Meets eMarketing
- Sales Force Effectiveness Metrics: More Important Than Ever in a Tough Market
- Sales Rep Assessment: Shoot the Messenger, the Message, or Both?
- Sales Reps Debate Their Value
- Scenarios on the Future of Pharma Marketing: No Time Like the Present to Think the Unthinkable
- Search Advertising Options for Pharma
- Searching for Answers on Search Engine Marketing?
- Separation of Church and State
- Should Bloggers Dine at Pharma’s Table?
- SiCKO is Boffo but Not Anti-Pharmaco Per Se
- Slides: The Currency of Communication
- Social Communications in Healthcare: Summary of Roundtable Discussions
- Social Media Adverse Event Reporting Safe Harbors: It’s Time for FDA to Open Up the Internet to Rx Advertising Like It Did with TV!
- Social Media and the Limitations of Disease Awareness Campaigns
- Social Media–Opportunity or Nightmare?
- Social Media & the Truncated News Pyramid
- Social Media Leaders Wanted
- Social Network Marketing: The Wisdom of the Crowd
- Socially Challenged Pharma: How Ready is Pharma to Engage In Social Media?>
- Society of Industry Leaders: Help for Investors
- Up Front: Solving the Adherence Problem in Economic Hard Times
- Solving the Social Media Adverse Event Reporting Problem
- Spam spam spam spam. Lovely spam! Wonderful spam!
- The State of CME in Europe
- Stop Wasting $Millions on Ineffective DTC Ads!
- Straight-Talking DTC Survey Results
- A Strategic Approach to CME Offers High Return on Education Investment
- Strategies for Enhanced Physician Targeting and Segmentation
- Strategies for Overcoming the Internal Challenges between Rx and OTC
- Super Bowl DTC Debut: Was It Good for You?
- Surfing the eMarketing Big One!
- Surveys Say…
- Surviving the Election Wars
- Up Front: Syndication is da Bomb!
T…
- Tailoring CRM Solutions to Your Business Strategy
- A Tale of Two Pharma Whistleblower Novels
- Targeted Faith-based Disease Awareness Marketing
- The Targeted Model: The Future of Pharmaceutical Marketing?
- Teaching New Dogs Old Tricks
- Texas Medical Privacy Act: A Wolf in Sheep’s Clothing?
- Thought-Leader Management: A Challenge Met
- Times They Are A-Changing?
- Tips for Improving Pharma Sales
- To Ban or Not to Ban DTC, That is the Question
- To Build Patient Adherence, Pfizer Puts Technology Behind The Curtain
- Top Companies, Classes, and Products in the DTC Space
- The Truth About the Drug Companies: What To Do About It
- Translate Industry Trends into the Optimal Promotional Strategy
- Transparency is the Word These Days
- Trends in Commercial Support of CME
- “Tribal Marketing”
- Turning Science into Sales
U…
- Understanding Drivers of Patient Behavior to Maximize DTC Effectiveness
- Understanding the Proposed ACCME Standards for Commercial Support
- Understanding the Strategic Value of MSLs
- Use of Behavioral Targeting by Pharma Marketers
- Use of Celebrities for PR and DTC Advertising
- Use of Social Media for Health Purposes in the EU
- Use of Twitter for Patient Support
V…
- Value-based Pricing
- The View From ePharma Summit: Practicing What Was Being Preached!
- Vioxx Withdrawal and the “Me-Too Drug Domino Effect”
W…
- Waiting for Goduidance (pdf)
- Waning Pharma Support of CME: The Plight of For-Profit MECCs
- Want to Know What Really Sucks?
- A Web-based Therapy Management Program
- Web 2.0 Pharma Marketing Tricks for Dummies
- What Americans Think About Drug Advertising
- What If There Were No Rules in Pharma Marketing?
- What Pharma Companies Spend on Gifts to Docs
- What Stands in the Way of the Mainstream Use of the Internet by Pharmaceutical Companies?
- What the Next Generation Physician Wants from Pharma
- What You Need to Know About the New “CAN-SPAM” Law
- What’s Next from the FDA?
- What’s Next vs. What’s Best
- Up Front: What’s Your Social Media Implementation Plan?
- When Is Commercial Support Appropriate for CME Activities?
- Who’s Better for Pharma: Obama or McCain?
- Whose Data Is It Anyway?
- Why Pharma Can’t Ignore eDetailers
- Why Pharmaceutical Marketers Ignore ROI
- Will COX-2 Inhibitors Crash and Burn?
- Will Healthcare be Rationed or Rational?: A Case for Supporting Comparative Effectiveness Research
- Will the Drug Industry be the Next Auto Industry?
- Whither CME?
- Whither Twitter for Pharma?
- Women in Pharma
- Word-of-Net
Y…